SynthesisPloS one2020

Refractory overactive bladder patients who chose sacral neuromodulation therapy after failed OnabotulinumtoxinA treatment: A systematic review and meta-analysis.

Guang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.